Cited by 976Skin Protection and AgingNonmelanoma Skin Cancer StudiesCutaneous Melanoma Detection and Management

Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial

Green, Adèle, Williams, Gail, Nèale, Rachel, Hart, Veronica, Leslie, David, Parsons, Peter, Marks, Geoffrey C, Gaffney, Philip +4 more·1999·The Lancet

Abstract

Background The use of sunscreens on the skin can prevent sunburn but whether long-term use can prevent skin cancer is not known. Also, there is evidence that oral betacarotene supplementation lowers skin-cancer rates in animals, but there is limited evidence of its effect in human beings. Methods In a community-based randomised trial with a 2 by 2 factorial design, individuals were assigned to four treatment groups: daily application of a sun protection factor 15-plus sunscreen to the head, neck, arms, and hands, and betacarotene supplementation (30 mg per day); sunscreen plus placebo tablets; betacarotene only; or placebo only. Participants were 1621 residents of Nambour in southeast Queensland, Australia. The endpoints after 4.5 years of follow-up were the incidence of basal-cell and squamous-cell carcinomas both in terms of people treated for newly diagnosed disease and in terms of the numbers of tumours that occurred. Analysis of the effect of sunscreen was based only on skin cancers that developed on sites of daily application. All analyses were by intention to treat. Findings 1383 participants underwent full skin examination by a dermatologist in the follow-up period. 250 of them developed 758 new skin cancers during the follow-up period. There were no significant differences in the incidence of first new skin cancers between groups randomly assigned daily sunscreen and no daily sunscreen (basal-cell carcinoma 2588 vs 2509 per 100,000; rate ratio 1.03 [95% CI 0.73-1.46]; squamous-cell carcinoma 876 vs 996 per 100,000; rate ratio 0.88 [0.50-1.56]). Similarly, there was no significant difference between the betacarotene and placebo groups in incidence of either cancer (basal-cell carcinoma 3954 vs 3806 per 100,000; 1.04 [0.73-1.27]; squamous-cell carcinoma 1508 vs 1146 per 100,000; 1.35 [0.84-2.19]). In terms of the number of tumours, there was no effect on incidence of basal-cell carcinoma by sunscreen use or by betacarotene but the incidence of squamous-cell carcinoma was significantly lower in the sunscreen group than in the no daily sunscreen group (1115 vs 1832 per 100,000; 0.61 [0.46-0.81]). Interpretation There was no harmful effect of daily use of sunscreen in this medium-term study. Cutaneous squamous-cell carcinoma, but not basal-cell carcinoma seems to be amenable to prevention through the routine use of sunscreen by adults for 4.5 years. There was no beneficial or harmful effect on the rates of either type of skin cancer, as a result of betacarotene supplementation.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(98)12168-2

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Green, A., Williams, G., Nèale, R., Hart, V., Leslie, D., Parsons, P., Marks, G. C., Gaffney, P., Battistutta, D., Frost, C., Lang, C., & Russell, A.
Affiliations
  • The University of Queensland (AU)
  • Griffith University (AU)
  • QIMR Berghofer Medical Research Institute (AU)
Corresponding author
Green, Adèle
Venue
The Lancet
Publisher
Elsevier BV
Published
1999-08
Volume
354
Issue
9180
Pages
723-729
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2135825792
Cited by
976
References
1
Citations by year
2026: 11 · 2025: 21 · 2024: 32 · 2023: 32 · 2022: 24 · 2021: 33 · 2020: 29 · 2019: 39 · 2018: 33 · 2017: 30 · 2016: 42 · 2015: 43 · 2014: 49 · 2013: 32 · 2012: 51
FWCI
38.17
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
  • Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
Keywords
sunscreen, basal cell carcinoma, squamous cell carcinoma, skin cancer prevention, sun protection, sun protection factor, vitamin A, sunburn, skin cancer incidence, tumor burden, skin cancer screening, sun protection behavior
MeSH terms
Adult, Aged, Carcinoma, Basal Cell, Basal Cell Carcinoma, Carcinoma, Squamous Cell, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Radiation-Induced, Queensland, Skin Neoplasms, Sunscreening Agents, beta Carotene

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review